Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Wagner Martin |

Präsentationen bei wissenschaftlichen Veranstaltungen

Wurm, P; Kump, P; Gröchenig, HP;Wenzl, HH; Petritsch, W; Halwachs, B; Wagner, M; Stadlbauer-Köllner, V; Eherer, AJ; Hoffmann, KM; Deutschmann, A; Reicht, G; Reiter, L; Slawitsch, P; Gorkiewicz, G; Högenauer, C;
;

 

Douschan, P; Kovacs, G; Stadlbauer, V; Kniepeiss, D; Krones, E; Durchschein, F; Rainer, F; Spindelboeck, W; Wagner, M; Zollner, G; Avian, A; Fickert, P; Olschewski, A; Olschewski, H; Stauber, RE Exercise capacity and exercise hemodynamics in the screening for pulmonary vascular disease (PVD) in patients with portal hypertension - results from a prospective cross-sectional study
J HEPATOL. 2017; 66(1):S568-S569.-International Liver Congress / 52nd Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 19-23, 2017; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Grande, P; Horvath, A; Wagner, M; Stadlbauer, V FGF21 and its connection to alcohol consumption
WIEN KLIN WOCHENSCHR. 2016; 128: S384-S384. [Poster]
Web of Science

 

Krones, E; Bork, T; Grahammer, F; Wagner, M; Rosenkranz, AR; Huber, TB; Fickert, P ACCUMULATION OF LC3 II IN CHOLEMIC NEPHROPATHY IS CAUSED BY BLOCKAGE OF AUTOPHAGIC FLUX
NEPHROL DIAL TRANSPL. 2016; 31: 103-104.-53rd ERA-EDTA Congress; MAY 21-24, 2016; Vienna, AUSTRIA. [Poster]
Web of Science

 

Panzitt, K; Marschall, HU; Moore, DD; Trauner, MH; Fickert, P; Wagner, M The autophagy inhibitor Rubicon is a direct target of the bile acid receptor FXR in human liver and is induced in human cholestasis
HEPATOLOGY. 2016; 63(1 SUPP):159A-159A.-67th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 11-15, 2016; Boston, MA. [Poster]
Web of Science

 

Panzitt, K; Marschall, HU; Trauner, M; Fickert, P; Wagner,M; The autophagy inhibitor Rubicon is a direct FXR target in human liver and is induced in human cholestasis
Proceedings of the XXIV International Bile Acid Meeting. 2016; -XXIV International Bile Acid Meeting: Bile Acids in Health and Disease; JUN 17-18, 2016; Düsseldorf, GERMANY. [Poster]

 

Panzitt,K; Marschall, HU; Trauner, M; Fickert, P; Wagner, M; The autophagy inhibitor Rubicon is a direct target of the bile acid receptor FXR in human liver and is induced in human cholestasis
Keystone Symposia Abstract Book "Autophagy: Molecular and physiological mechanisms". 2016; -Autophagy: Molecular and Physiological Mechanisms (V1); JUN 5-9, 2016; Whistler, British Columbia, CANADA. [Poster]

 

PK Kump, P Wurm, HP Gröchenig, HH Wenzl, w Petritsch, B Halwachs, M wagner, V. Stadlbauer-Köllner, AJ Eherer, KM Hoffmann, A Deutschmann, G Reicht, L Reiter, P Slawitsch, G Gorkiewicz, C Högenauer Clinical Response to fecal microbiota Transplantation in chronic active ulcerative colitis depends on the taxonomic composition of the donor microbiota.
United European Gastroenterology Journal; 2016:2 (Supplement 1) . 2016; 2: -UEG week; 15.-19.10.2016; Wien. [Oral Communication]

 

Schuller, M; Wagner, M; Panzitt, K Endogenous phosphatidylcholine generation via the PEMT pathway modulates LRH-1 signaling - Dietary clues for treating NAFLD?
WIEN KLIN WOCHENSCHR. 2016; 128: S383-S384. [Poster]
Web of Science

 

Wagner, M; Cholestatische Lebererkrankungen
Lebertag Graz; FEB 27, 2016; Graz, AUSTRIA. 2016. [Oral Communication]

 

Wagner, M; Nutzen und Schaden von Gallensäuren: Von der Noxe zum Hormon und Biomarker
Viszeralmedizin 2016; SEP 21-24, 2016; Hamburg, GERMANY. 2016. [Oral Communication]

 

Wagner, M; Inhibition of Autophagy by Bile Acids and in Cholestasis
16. Pichlschloss Transport Weekend 2016; JUL 7-10, 2016; Neumarkt, AUSTRIA. 2016. [Oral Communication]

 

Panzitt, K; Marschall, H-U; Trauner, M; Fickert, P; Wagner, M; Effects of Ursodeoxycholic-acid and Rifampicin on autophagy in the liver
Hepatology. 2015; -AASLD 2015; 13.11. - 17.11.2015; San Francisco. [Poster]

 

Panzitt, K; Marschall, H-U; Trauner, M; Fickert, P; Wagner, M; Effects of Ursodeoxycholic-acid and Rifampicin on autophagy in the liver
UEG Journal. 2015; -UEG Week 2015; 24.10. - 28.10.2015; Barcelona. [Poster]

 

Panzitt, K; Marschall, H-U; Trauner, M; Fickert, P; Wagner, M; Effekte von Ursodeoxycholsäure und Rifampicin auf Autophagie in der Leber
ÖGGH Jahrestagung 2015; 18.6. - 20.6.2015; Salzburg. 2015. [Poster]

 

Panzitt, K; Marschall, HU; Trauner, M; Fickert, P; Wagner, M Effects of Ursodeoxycholic-acid and Rifampicin on autophagy in the liver
HEPATOLOGY. . 2015; 62: 538A-538A.-66th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 13-17, 2015; San Francisco, CA. [Oral Communication]
Web of Science

 

Wagner, M; Regulation of Autophagy by Nuclear Receptors and Bile Acids
Digestive Disease Research Seminar ; 21.10.2015; Vienna. 2015. [Oral Communication]

 

Wagner, M; LRH-1 and the methyl pool
16. Pichlschloss Transport Weekend 2015; 3.7.2015; Neumarkt. 2015. [Oral Communication]

 

Wagner, M; Genetic Landscape of FXR in NAFLD in Human - a systems-biological approach
3. Maria Troster Lebertage; 21.5.2015; Graz. 2015. [Oral Communication]

 

Douschan, P; Kovacs, G; Stadlbauer-Koellner, V; Spindelboeck, W; Krones, E; Durchschein, F; Zollner, G; Rainer, F; Foris, V; Wagner, M; Fickert, P; Olschewski, H; Stauber, RE Cardiopulmonary response to exercise in patients with portal hypertension and early stages of liver cirrhosis.
Z Gastroenterol. 2014; 52 - P66: -47. Jahrestagung der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); 12. – 14. Juni, 2014; Villach, AUSTRIA. [Poster]

 

Zaufel, A; Wagner, M; Krones, E; Fickert, P; Zollner, G Cholestasis and Bile Acids start the Adrenocortical Function, Salzburg, 25th-27th September, 2014
WIEN KLIN WOCHENSCHR. 2014; 126(17-18):570-571. [Poster]
Web of Science

 

Zaufel, A; Wagner, M; Krones, E; Fickert, P; Zollner, G. Cholestasis and Bile Acids Alter Adrenocortical Function
Proceedings of the XXIII International Bile Acid Meeting. 2014; -Falk Symposum, XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY. [Poster]

 

Zaufel, A; Wagner, M; Krones, E; Fickert, P; Zollner, G. Cholestasis and Bile Acids Alter Adrenocortical Function
Proceedings of the XXIII International Bile Acid Meeting. 2014; -Falk Symposium: XXIII International Bile Acid Meeting; OCT 8-9, 2014; Freiburg, GERMANY. [Oral Communication]

 

Mueller, M; Marschall, HU; Claudel, T; Wagner, M; Fickert, P; Lackner, C; Einarsson, C; Thorell, A; Trauner, M URSODEOXYCHOLIC ACID COUNTERACTS LIPOTOXICITY AND INDUCES UNFOLDED PROTEIN RESPONSE IN MORBIDLY OBESE PATIENTS
J HEPATOL. . 2013; 58: S517-S517.-International Liver Congress / 48th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 24-28, 2013; Amsterdam, NETHERLANDS. [Poster]
Web of Science

 

Marschall, HU; Mueller, M; Claudel, T; Wagner, M; Fickert, P; Zollner, G; Silbert, D; Lackner, K; Thorell, A; Trauner, M High Levels of Ursodeoxycholic Acid Act as FXR Antagonist and Deplete Liver Cholesterol due to Increased Bile Acid Synthesis in Morbidly Obese Patients.
classic paper presentation, electronic posters on the EASL member restricted website. 2012; -International Liver Congress(TM) 2012 by EASL; April 18-22, 2012; Barcelona, Spain. [Poster]

 

Marschall, HU; Mueller, M; Wagner, M; Fickert, P; Zollner, G; Silbert, D; Lackner, C; Thorell, A; Trauner, M HIGH LEVELS OF URSODEOXYCHOLIC ACID ACT AS FXR ANTAGONIST AND DEPLETE LIVER CHOLESTEROL DUE TO INCREASED BILE ACID SYNTHESIS IN MORBIDLY OBESE PATIENTS
J HEPATOL. . 2012; 56: S515-S515.-47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL); APR 18-22, 2012; Barcelona, SPAIN. [Poster]
Web of Science

 

Wagner, M; Wooton-Kee, CR; Mamrosh, JL; Lee, JM; Xiao, R; Vareed, SK; Sreekumar, A; Moore, DD LRH-1 is a key regulator of carbon one metabolism and its loss protects from liver injury in the methionine-choline deficient NASH model
HEPATOLOGY. 2012; 56: 866A-867A.-63rd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); NOV 09-13, 2012; Boston, MA.
Web of Science

 

Mader, JK; Bock, G; Wagner, M; Forrer, F; Lackner, C; Portugaller, RH; Fickert, P; Krejs, GJ; Pieber, TR Recurrent hypoglycemia in adults - a diagnostic challenge (case report).
WIEN KLIN WOCHENSCHR. 2010; 122(17-18):A7-A7.-ÖGIM; Sep 29-Oct. 1; Salzburg, Austria. [Poster]
Web of Science

 

Mader, JM; Bock, G; Wagner, M; Forrer,F; Lackner, C; Portugaller, RH; Fickert, P; Krejs, GJ; Pieber, TR; Rezidivierende Hypoglykämie im Erwachsenenalter - eine diagnostische Herausforderung (Fallbericht).
Abstractband. 2010; -ÖGIM; 29.9-2.10.2010; Salzburg, Austria. [Poster]

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; Marz, W; Wascher, TC; Trauner, M LOW-DOSE ATORVASTATIN IMPROVES DYSLIPIDEMIA AND VASCULAR FUNCTION IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS AFTER ONE YEAR OF TREATMENT.
J HEPATOL. 2010; 52: S431-S432.-45th Annual Meeting of the European Association for the Study of the Liver (EASL); APR 14-18, 2010; Vienna, AUSTRIA. [Poster]
Web of Science

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
3rd Annual Congress of the Austrian Society for Laboratory Medicine and Clinical Chemistry; OCT 27-30, 2010; Salzburg, AUSTRIA. 2010. [Oral Communication]

 

Klein, K; Eloranta, JJ; Wagner, M; Trauner, M; Kullak-Ublick, GA Regulation of human concentrative nucleoside transporter-1 gene expression
NAUNYN-SCHMIED ARCH PHARMACOL. 2009; 379: 490- [Oral Communication]
Web of Science

 

Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Lundasen, T; Gustafsson, U; Sahlin, S; Trauner, M STIMULATION OF HEPATOBILIARY DETOXIFICATION AND TRANSPORT SYSTEMS IN HUMAN LIVER BY COMBINED TREATMENT WITH RIFAMPICIN AND URSODEOXYCHOLIC ACID
J HEPATOL. 2009; 50: 675-Vienna, Austria. [Poster]
Web of Science

 

Marshall, H; Wagner, M; Zoller, G; Fickert, P; Gustafsson, U; Sahlin, S; Trauner, M Combined treatment with rifamppicin and ursodeoxycholic acid in humans stimulates bile acid synthesis, detoxification and bilirubin elimination.
Gut2009; 58(SII):A49-A49.-GASTRO 2009 UEGW/WCOG; NOV 21-25,2009; London, GREAT BRITAIN. [Oral Communication]

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment.
39. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 26-28, 2009; Maikammer, GERMANY. 2009. [Oral Communication]

 

Stojakovic, T; Claudel, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; Winkler, K; März, W; Wascher, TC; Trauner, M Improvement of lipoprotein pattern and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
1st Styrian Conference on Lipid Mass Spectrometry; OCT 21-22, 2009; Graz, AUSTRIA. 2009. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, M; Wagner, M; Sourij, H; Stauber, RE; Marz, W; Wascher, TC; Trauner, M Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment
WIEN KLIN WOCHENSCHR. 2009; 121(15-16):A26-A26.-40.Jahrestagung der Österreichischen Gesellschaft für Innere Medizin (ÖGIM); SEP 17-19, 2009; Vienna, AUSTRIA. [Poster]
Web of Science

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Sourij, H; Stauber, RE; März, W; Wascher, TC; Trauner, M Improvement of dyslipidemia and vascular function in patients with primary biliary cirrhosis after long-term treatment with atorvastatin.
Clin Chem Lab Med. 2008; 46(9):A181-A181.-5. Jahrestagung der Deutschen Vereinten Gesellschaft für Klinische Chemie und Laboratoriumsmedizin (DGKL); SEP 21-24, 2008; Mannheim, GERMANY. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Sourij, H; März, W; Wascher, TC; Trauner, M Long-term treatment with atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis.
Z Gastroenterol. 2008; 45: 1-1.-41. Jahrestagung und 19. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie (ÖGGH); MAI 29-31, 2008; Millstatt, AUSTRIA. [Oral Communication]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Sourij, H; März, W; Wascher, TC; Trauner, M Long-term treatment with atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis.
15. Jahrestagung der Österreichischen Atherosklerosegesellschaft - Austrian Atherosclerosis Society (AAS); APR 18-19, 2008; St. Gilgen, AUSTRIA. 2008. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Scharnagl, H; Wagner, M; Wascher, TC; März, W; Trauner, M. Improvement of dyslipidemia and vascular function in patients with cholestatic liver disease after long-term treatment with atorvastatin
Hämostaseologie. 2008; 28(1-2):A62-A62.-52. Jahrestagung der Gesellschaft für Thrombose- und Hämostaseforschung e. V. (GTH); FEB 20-23, 2008; Wiesbaden, Germany. [Poster]

 

Stojakovic, T; Putz-Bankuti, C; Wagner, M; Scharnagl, H; Wascher, TC; Marz, W; Trauner, M Long-term treatment with atorvastatin in patients with cholestatic liver disease.
ATHEROSCLER SUPPL 2008; 9(1):197-197.-77th Congress of the European Atherosclerosis Society; APR 26-29, 2008; Istanbul, TURKEY. [Poster]

 

Jahnel, J; Wagner, M; Langner, C; Hoegenauer, C; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Denk, H; Trauner, M Impact of colitis on bile secretion and hepatobiliary transporter expression in mice possible implications for pathogenesis of sclerosing cholangitis
J HEPATOL. 2007; 46: S122-S122. [Poster]
Web of Science

 

Wagner, M; Moustafa, T; Fickert, P; Zollner, G; Gumhold, J; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Absence of FXR protects mice from bile-infarcts in biliary obstruction by reduction of bile acid-independent bile flow: Implications for targeting FXR in treatment of cholestasis?
J HEPATOL. 2007; 46: S5-S5.-42th Annual Meeting, European Association for the Study of the Liver; April, 11-15, 2007; Barcelona, Spain. [Oral Communication]
Web of Science

 

Zollner, G; Caligiuri, A; Fickert, P; Wagner, M; Silbert, D; Pinzani, M; Trauner, M Expression of bile acid transport and detoxification systems and their regulatory nuclear receptors in human hepatic stellate cells
J HEPATOL. 2007; 46: S135-S135.-42th Annual Meeting, European Association for the Study of the Liver ; April 11-15, 2007; Barcelona, Spain. [Poster]
Web of Science

 

Moustafa, T; Fickert, P; Prokesch, A; Wagner, M; Fuchsbichler, A; Silbert, D; Gumhold, J; Denk, H; Trajanoski, Z; Trauner, M Common bile-duct-ligation of FXR knockout mice results in severe hepatic steatosis due to enhancement in lipogenic gene expression
J HEPATOL. 44: S28-S28.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. [Poster]
Web of Science

 

Wagner, M Effects of UDCA on intestinal bile acid signalling in cholestasis.
7. Pichlschloß Transport Wochenende; JULI 6-9,; Neumarkt/ Steiermark. 2006. [Oral Communication]

 

Wagner, M; Fickert, P; Zollner, G; Trauner, M 24-nor-ursodeoxycholic acid ameliorates sclerosing cholangitis in Mdr2 knockout mice.
4th Central European Gastroenterology Meeting; Juni 29 - Juli 2; Visegrad, Ungarn. 2006. [Oral Communication]

 

Wagner, M; Halilbasic, E; Marschall, HU; Zollner, G; Fickert, P; Langner, C; Zatloukal, K; Denk, H; Trauner, M CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice.
Forum Forschung, Sanofi-Aventis Preisverleihung; NOV 8; Graz. 2006. [Oral Communication]

 

Zollner, G; Wagner, M; Moustafa, T; Fickert, P; Silbert, D; Gumhold, J; Helmut, D; Marschall, HU; Trauner, M Role of nuclear bile acid receptor FXR in regulation of bile acid detoxification and organic solute transporter (OST-alpha/beta) expression in bile acid-fed mice
J HEPATOL. 44: S124-S124.-41st Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 26-30, 2006; Vienna, AUSTRIA. [Poster]
Web of Science

 

Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Krause, R; Zatloukal, K; Marschall, HU; Jaeschke, H; Denk, H; Trauner, M Lithocholic acid feeding induces biliary obstruction and destructive cholangitis in mice
J HEPATOL. 2005; 42: 113-113.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science

 

Fickert, P; Wagner, M; Marshall, HU; Fuchsbichler, A; Zollner, G; Zatloukal, K; Liu, J; Waalkes, MP; Cover, C; Denk, H; Hofmann, AF; Jaeschke, H; Trauner, M 24-norursodeoxycholic acid as novel therapeutic approach to sclerosing cholangitis in Mdr2 (ABCB4) knockout mice
HEPATOLOGY. 2005; 42: -56th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases; NOV 11-15, 2005; San Francisco, CA.
Web of Science

 

Geier, A; Zollner, G; Dietrich, CG; Wagner, M; Fickert, P; Denk, H; van Rooijen, N; Matern, S; Gartung, C; Trauner, M Cytokine-independent repression of rodent Ntcp in obstructive cholestasis
J HEPATOL. 2005; 42: 114-114.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science

 

Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Diczfalusy, U; Benthin, L; Grundstrom, R; Gustafsson, U; Sahlin, S; Einarsson, C; Trauner, M Complementary stimulation of hepatobiliary transport and detoxification systems by rifampicin and ursodeoxycholic acid in human liver
GASTROENTEROLOGY. 2005; 128: A755-A755.
Web of Science

 

Stojakovic, T; Putz-Bankuti, C; Fauler, G; Scharnagl, H; Wagner, M; Stadlbauer, V; Gurakuqi, G; Stauber, RE; März, W; Trauner, M Atorvastatin in patients with primary biliary cirrhosis and an incomplete response to ursodeoxycholic acid.
35. Jahrestagung des Arbeitskreises "Klinischer Lipidstoffwechsel"; NOV 25-27, 2005; Maikammer, Deutschland. 2005. [Oral Communication]

 

Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Gujral, J; Zatloukal, K; Jaeschke, H; Deck, H; Trauner, M Role of inflammation for hepatobiliary transporter expression in ICAM-/- and lpr mice after common bile duct ligation
GASTROENTEROLOGY. 2005; 128: A89-A89.
Web of Science

 

Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Gujral, JS; Zatloukal, K; Denk, H; Jaeschke, H; Trauner, M Alterations of hepatobiliary transporter expression in response to common bile duct ligation in mice are independent of ICAM-1 and FAS-receptor expression
J HEPATOL. 2005; 42: 115-115.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science

 

Zollner, G; Wagner, M; Fickert, P; Gumhold, J; Silbert, D; Marschall, HU; Denk, H; Trauner, M Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis
GASTROENTEROLOGY. 2005; 128: A691-A691.
Web of Science

 

Zollner, G; Wagner, M; Fickert, P; Gumhold, J; Silbert, D; Marschall, HU; Denk, H; Trauner, M Expression of key bile acid detoxification enzymes and the alternative bile acid export pump MRP4 in primary biliary cirrhosis
J HEPATOL. 2005; 42: 240-240.-40th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 13-17, 2005; Paris, FRANCE.
Web of Science

 

Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Kaser, A; Tilg, H; Krause, R; Langner, C; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Bile acids regurgitation from leaky bile ducts causes sclerosing cholangitis in Mdr2 knockout mice
GASTROENTEROLOGY. 2004; 126: A663-A663.
Web of Science

 

Fickert, P; Fuchsbichler, A; Wagner, M; Zollner, G; Kaser, A; Tilg, H; Krause, R; Langner, C; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Biliary leakage of fluorescent bile acids in MDR2 knockout mice: Evidence for a critical role of bile duct leakage in the pathogenesis of sclerosing cholangitis
J HEPATOL. 2004; 40: 91-91.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Web of Science

 

Fickert, P; Trauner, M; Fuchsbichler, A; Zollner, G; Wagner, M; Marschall, HU; Zartloukal, K; Denk, H; Zsengeller, Z; Szabo, C Oncosis represents the main type of cell death in mouse models of cholestasis: evidence for a critical role of poly(ADP-ribose) polymerase (PARP) activation in bile acid-induced hepatocytes death
FASEB J. 2004; 18: A558-A558.-Experimental Biology 2004 Meeting; APR 17-21, 2004; Washington, DC.
Web of Science

 

Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Diczfalusy, U; Benthin, L; Grundstrom, R; Sahlin, S; Einarsson, C; Trauner, M Comprehensive study of the effects of rifampicin and ursodeoxycholic acid on genes and proteins involved in regulation, transport and detoxification of biliary compounds in gallstone patients
GASTROENTEROLOGY. 2004; 126: A746-A746.
Web of Science

 

Marschall, HU; Wagner, M; Zollner, G; Fickert, P; Gumholdt, J; Silbert, D; Diczfalusy, U; Benthin, L; Grundstrom, R; Sahlin, S; Einarsson, C; Trauner, M Comprehensive study of the effects of rifampicin and ursodeoxycholic acid on genes and proteins involved in regulation, transport and detoxification of biliary compounds in gallstone patients
J HEPATOL. 2004; 40: 93-93.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Web of Science

 

Wagner, M; Fickert, P; Marschall, HU; Zollner, G; Silbert, D; Fuchsbichler, A; Gumhold, J; Schuetz, JD; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M Alternative exretory routes for accumulating bile acids via adaptive renal ABC transporter expression in common bile duct-ligated (CBDL) mice
GASTROENTEROLOGY. 2004; 126: A129-A130.
Web of Science

 

Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Gu, GL; Marschall, HU; Denk, H; Trauner, M Role of adaptive hepatobiliary transporter expression and regulation of bile acid synthetic enzymes in MDR2-/- mice: A model for chronic cholestatic liver disease due to sclerosing cholangitis
J HEPATOL. 2004; 40: 163-163.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Web of Science

 

Wagner, M; Fickert, P; Zollner, G; Silbert, D; Fuchsbichler, A; Gumhold, J; Schuetz, JD; Gonzalez, FJ; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Adaptive renal ABC transporter expression in common bile duct-ligated mice
J HEPATOL. 2004; 40: 26-26.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Web of Science

 

Wagner, M; Fickert, P; Zollner, G; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Hepatic and renal ABC transporter expression in mice depends on gender and changes in pregnancy
GASTROENTEROLOGY. 2004; 126: A130-A130.
Web of Science

 

Wagner, M; Fickert, P; Zollner, G; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Gender and pregnancy affect hepatic and renal ABC transporter expression in mice
J HEPATOL. 2004; 40: 94-94.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Web of Science

 

Wagner, M; Halilbasic, E; Fickert, P; Zollner, G; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Denk, H; Trauner, M Nuclear receptor (PXR, CAR) agonists induce adaptive hepatic transporter and enzyme expression in mouse liver
J HEPATOL. 2004; 40: 25-25.-39th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; APR 14-18, 2004; Berlin, GERMANY.
Web of Science

 

Wagner, M; Halilbasic, E; Zollner, G; Fickert, P; Gumhold, J; Silbert, D; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Xenobiotic nuclear receptor (PXR, CAR) agonists coordinately stimulate a spectrum of detoxification enzymes and transport systems involved in the adaptive response to cholestasis in vivo.
HEPATOLOGY. 2004; 40: 489A-489A.-55th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD); OCT 29-NOV 02, 2004; Boston, MA.
Web of Science

 

Zollner, G; Halilbasic, E; Wagner, M; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Differential effects of ursodeoxycholic acid (UDCA) and cholic acid (CA) on hepatic and renal expression of MRP4 and MRP6, two novel abc transporters, in mice
J HEPATOL. 2004; 40: 25-25.
Web of Science

 

Zollner, G; Halilbasic, E; Wagner, M; Fickert, P; Silbert, D; Gumhold, J; Fuchsbichler, A; Zatloukal, K; Denk, H; Trauner, M Cholic acid (CA) and ursodeoxycholic acid (UDCA) exert different effects on hepatic and renal expression of Mrp4 and Mrp6, two novel ABC transporters
GASTROENTEROLOGY. 2004; 126: A16-A16.
Web of Science

 

Zollner, G; Wagner, M; Fickert, P; Fuchsbichler, A; Gumhold, J; Silbert, D; Zatloukal, K; Guo, GL; Marschall, HU; Denk, H; Trauner, M Mdr2(-/-) mice with sclerosing cholangitis: A model of chronic cholestasis to study the role of the adaptive response of hepatobiliary transport systems and bile acid synthetic enzymes
GASTROENTEROLOGY. 2004; 126: A751-A751.
Web of Science

 

Fickert, P; Trauner, M; Fuchsbichler, A; Zollner, G; Wagner, M; Zenz, R; Zsengeller, Z; Szabo, C; Denk, H Inhibition of poly(ADP-ribose) polymerase (PARP) protects mice from cholestatic liver injury.
HEPATOLOGY 2003 38: 576A-576A.
Web of Science

 

Wagner, M; Fickert, P; Fuchsbichler, A; Silbert, D; Gumhold, J; Zollner, G; Zatloukal, K; Marschall, HU; Schuetz, JD; Gonzalez, FJ; Denk, H; Trauner, M Hepatic and renal ABC transporter expression as critical determinants of ursodeoxycholic acid-induced bile infarcts in bile duct-ligated mice.
HEPATOLOGY 2003 38: 688A-689A.
Web of Science

 

Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Silbert, D; Marschall, HU; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M The role of the bile acid receptor FXR in determining ATP-binding cassette (ABC) transporter expression and liver injury in common bile duct ligated (CBDL) mice
J HEPATOL 2003 38: 190-190.
Web of Science

 

Wagner, M; Fickert, P; Zollner, G; Fuchsbichler, A; Silbert, D; Tsybrovskyy, O; Gonzalez, FJ; Zatloukal, K; Marschall, HU; Denk, H; Trauner, M Role of nuclear bile acid receptor, FXR, in determining ATP-binding cassette (ABC) transporter expression and cholestatic liver injury in common bile duct-ligated mice
GASTROENTEROLOGY 2003 124: A697-A698.
Web of Science

 

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Guo, G; Gonzalez, FJ; Zatloukal, K; Denk, H; Trauner, M Role of nuclear bile salt receptors Fxr and Pxr in mediating adaptive hepatobiliary transporter response to cholic acid (CA) in mouse liver
GASTROENTEROLOGY 2003 124: A59-A59.
Web of Science

 

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Zatloukal, K; Denk, H; Trauner, M Regulation of the Na+/taurocholate cotransporter Ntcp via short heterodimer partner (SHP)-dependent or SHP-independent mechanims depends on the type of cholestatic injury
GASTROENTEROLOGY 2003 124: A730-A730.
Web of Science

 

Zollner, G; Fickert, P; Silbert, D; Fuchsbichler, A; Wagner, M; Zatloukal, K; Denk, H; Trauner, M Role of short heterodimer partner (SHP) -dependent and -independent pathways for regulation of Na+/taurocholate cotransporter (NTCP) expression in cholestatic mouse models.
J HEPATOL. 2003; 38(2):9-10.-38th Annual Meeting of the European-Association-for-the-Study-of-the-Liver; MAR 29-APR 01, 2003; ISTANBUL, TURKEY.
Web of Science PubMed

 

Zollner, G; Fickert, P; Wagner, M; Fuchsbichler, A; Silbert, D; Gumhold, J; Zatloukal, K; Denk, H; Trauner, M Induction of intestinal multidrug resistance-associated proteins 2 and 3 (Mrp2, Mrp3) by cholic acid (CA) and ursodeoxycholic acid (UDCA) in mice.
HEPATOLOGY 2003 38: 689A-689A.
Web of Science

 

© Meduni Graz Impressum